---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-177317"
form_type: "8-K/A"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:11:18.693515+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AnaptysBio pro forma continuing ops net income $114.9M after First Tracks spin-off

## Summary
- Pro forma continuing ops net income $114.9M for FY2025; basic EPS $3.99, diluted $3.07.
- Collaboration revenue $234.6M, operating income $217.9M after spin-off adjustments.
- AnaptysBio provided $100M cash distribution to First Tracks; expects $7M non-recurring costs within 12 months.
- Pro forma balance sheet as of Dec 31, 2025 shows negative stockholders' equity of $116.3M.
- First Tracks shares began trading on Nasdaq under ticker TRAX on April 20, 2026.

## SEC filing metadata
- accession: 0001193125-26-177317
- form_type: 8-K/A
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000119312526177317/0001193125-26-177317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000119312526177317/d104779d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-177317
- JSON: https://secwatch.observer/filing/0001193125-26-177317.json
- Plain text: https://secwatch.observer/filing/0001193125-26-177317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.